Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Evaluate the Use of RenalGuard to Protect Patients at High Risk of AKI (STRENGTH)

NCT02793661 is registered in ClinicalTrials.gov with European Cardiovascular Research Center as lead sponsor.

NCT NCT02793661
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02793661 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Evaluate the Use of RenalGuard to Protect Patients at High Risk of AKI (STRENGTH)
Lead sponsor
European Cardiovascular Research Center
Phase
Not applicable
Overall status
Unknown status
Start date
May 31, 2016
Completion date
May 31, 2018
Enrollment
300 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, cardiovascular disease